FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for generic paroxetine filed by Modavar Pharmaceuticals LLC under ANDA212645.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Obsessive-compulsive Disorder
• Panic Disorder
• Post-traumatic Stress Disorder
• Social Anxiety Disorder

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

SUPPL AP for PAROXETINE (PAROXETINE)